Easy and efficient protocols for working with recombinant vaccinia virus MVA

Methods in Molecular Biology

Volumn 890, Issue , 2012, Pages 59-92

  Kremer, Melanie ^a   Volz, Asisa ^a   Kreijtz, Joost H C M ^a,b   Fux, Robert ^a   Lehmann, Michael H ^a   Sutter, Gerd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clinical testing; Genetic stability; Large scale production; Quality control; Vector vaccine; Viral vector

Indexed keywords

MODIFIED VACCINIA VIRUS ANKARA VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR; GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN; VIRUS DNA;

ANIMAL CELL; ARTICLE; BIOMEDICINE; BIOSAFETY; CONTROLLED STUDY; DNA RECOMBINATION; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC STABILITY; LARGE SCALE PRODUCTION; MODIFIED VACCINIA VIRUS ANKARA; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RECOMBINANT GENE; VACCINIA VIRUS; VIROGENESIS; VIRUS RECOMBINANT; ANIMAL; BIOSYNTHESIS; CHICK EMBRYO; CULTURE MEDIUM; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAMSTER; HAZARDOUS WASTE; HELA CELL; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; RABBIT; REPORTER GENE; VIRUS CULTURE; VIRUS LOAD; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHICK EMBRYO; CLONING, MOLECULAR; CONTAINMENT OF BIOHAZARDS; CRICETINAE; CULTURE MEDIA, SERUM-FREE; DNA, VIRAL; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; RABBITS; RECOMBINANT PROTEINS; VACCINIA VIRUS; VIRAL LOAD; VIRAL PLAQUE ASSAY; VIRUS CULTIVATION;

EID: 84866785687     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-876-4_4     Document Type: Article

References (19)

1. Moss B (1996) Genetically engineered poxvi-ruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci USA 93:11341-11348
2. Sutter G, Moss B (1992) Nonreplicating vaccinia vector Efficiently expresses recombinant genes. Proc Natl Acad Sci USA 89:10847-10851
3. Tartaglia J et al (1992) NYVAC: a highly attenuated strain of vaccinia virus. Virology 188:217-232
4. Acres B, Bonnefoy J-Y (2008) Clinical development of MVA-based therapeutic cancer vaccines. Expert Rev Vaccines 7:889-893
5. Gomez CE, Najera JL, Krupa M, Esteban M (2008) The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer. Curr Gene Ther 8:97-120
6. Rimmelzwaan GF, Sutter G (2009) Candidate in fluenza vaccines based on recombinant modi fied vaccinia virus Ankara. Expert Rev Vaccines 8:447-454
7. Kennedy JS, Greenberg RN (2008) IMVAMUNE ®: modi fied vaccinia Ankara strain as an attenuated smallpox vaccine. Expert Rev Vaccines 8:13-24
8. Mackett M, Smith GL, Moss B (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49:857-864
9. Cottingham MG, Gilbert SC (2010) Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial arti ficial chromosome. J Virol Methods 168:233-236
10. Domi A, Moss B (2005) Engineering of a vaccinia virus bacterial arti ficial chromosome in Escherichia coli by bacteriophage [lambda]-based recombination. Nat Meth 2:95-97
11. Wyatt LS et al (2009) Elucidating and minimizing the loss by recombinant vaccinia virus of human immunode ficiency virus gene expression resulting from spontaneous mutations and positive selection. J Virol 83:7176-7184
12. Meyer H, Sutter G, Mayr A (1991) Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their in fluence on virulence. J Gen Virol 72:1031-1038
13. Staib C et al (2000) Transient host range selection for genetic engineering of modi fied vaccinia virus Ankara. Biotechniques 28:1137-1142
14. Antonis AFG et al (2007) Vaccination with recombinant modi fied vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge. Vaccine 25:4818-4827
15. Staib C, Lowel M, Erfle V, Sutter G (2003) Improved host range selection for recombinant modi fied vaccinia virus Ankara. Biotech niques 34:694-696, 698, 700
16. Staib C, Drexler I, Sutter G (2004) Construction and isolation of recombinant MVA. Methods Mol Biol 269:77-100
17. Wong YC, Lin LC, Melo-Silva CR, Smith SA, Tscharke DC (2011) Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection. J Virol Methods 171:295-8
18. Renart J, Reiser J, Stark GR (1979) Transfer of proteins from gels to diazobenzyloxym-ethyl-paper and detection with antisera: a method for studying antibody speci ficity and antigen structure. Proc Natl Acad Sci USA 76:3116-3120
19. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from poly-acrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354